Indo Us Bio-Tech Ltd - 541304 - Submission Of Certificate Under Regulation 40(9) And 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 31St March, 2020
We are submitting herewith the certificate under Regulation 40(9) & 40(10) of the SEBI (LODR) Regulation 2015 obtained from Practicing Company Secretary for the half year ended on 31st March, 2020. Kindly take the same on your record. Thanking you Indo Us Bio-Tech Ltd - 541304 - Intimation Regarding Opening Of Branch Office
With reference to the captioned subject, we wish to inform that the Company has opened various Branch offices at the mentioned address and Company has also appointed appropriate parties in relation thereto. Indo Us Bio-Tech Ltd - 541304 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We herewith enclose a Certificate dated 6th April, 2020 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter/year ended 31st March, 2020 received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent of our company. Thanking you * Please note that, The Company has adopted 'Work from Home' due to the outbreak of COVID-19 as per the directives issued by Central and State Government. Hence, we are submitting Sd/- copy of the document. Indo Us Bio-Tech Ltd - 541304 - Compliance- Compliance Certificate For The Period Ended March, 2020
We hereby certify that all activities in relation to both physical and electronic share transfer facilities are maintained by our Registrar and Share Transfer Agent i.e. Bigshare Services Private Limited (SEBI Reg. No. INR000001385) having its Office at A/802, Samundra Complex, Near Klassic Gold, Girish cold drink, C.G. Road, Ahmedabad-380009, Gujarat. Further, we confirm that Bigshare Services Private Limited is registered with Securities and Exchange Board of India to act as Registrar and Transfer Agents. Further, pursuant to Regulation 7(3) of the LODR Regulations, we are submitting the compliance certificate for the half of the financial year ended on 31st March, 2020 i.e. for the period from October 1, 2019 to March 31, 2020. We request you to take this certificate on record. * Please note that, The Company has adopted 'Work from Home' due to the outbreak of COVID-19 as per the directives issued by Central and State Government. Hence, we are submitting Sd/- copy of the document. Indo Us Bio-Tech Ltd - 541304 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dimpy JoshiDesignation :- Company Secretary and Compliance Officer Indo Us Bio-Tech Ltd - 541304 - Shareholding for the Period Ended March 31, 2020
Indo Us Bio-Tech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here Indo Us Bio-Tech Ltd - 541304 - Closure of Trading Window
This is to inform you that in terms of Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company, pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, read with BSE vide circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019, the Trading Window for dealing in the Securities of the Company will remain closed from 1st April, 2020 till 48 hours after announcement / declaration of Audited financial results for the quarter and year ended 31st March, 2020. The date of Board Meeting for declaration of the financial results of the Company for the Quarter and year ended on March 31, 2020 will be intimated in due course. Please note that, The Company has adopted 'Work from Home' due to the outbreak of COVID-19 as per the directives issued by Central and State Government. Hence, we are submitting Sd/- copy of the document. Kindly take note of the same. Indo Us Bio-Tech Ltd - 541304 - Appointment of Company Secretary and Compliance Officer
Pursuant to provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated 9th September,2015, we wish to inform you that the Board of Directors of the Company at its meeting held on Friday, 24th January, 2020 has appointed Ms. Dimpy Joshi as a Company Secretary and Compliance Officer of the Company with effect from 24th January, 2020 pursuant to Section 203 of the Companies Act, 2013 and Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015. Further, Pursuant to provisions of Regulation 30(5) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, Ms. Dimpy Joshi is severelly authorized for the purpose of determining of an event or information and for the purpose of making disclosure with stock exchange. Indo Us Bio-Tech Ltd - 541304 - Outcome Of The Board Meeting Of The Company Held On Friday, 24Th January, 2020
This is to inform that a meeting of the Board of Directors of the Company was held today, Friday, 24th January, 2020 at 12.00 p.m. The Board of Directors have inter alia considered and approved the Appointment of Ms. Dimpy Joshi as a Company Secretary and Compliance Officer of the Company w. e. f 24th January, 2020. Brief Profile of Ms. Dimpy Joshi is herewith annexed as Table A. The meeting of Board of Directors of the company commenced at 12.00 p.m. and concluded at 12.30 p.m. Kindly take the same on your record.